From the Sector

ExxonMobil will present its portfolio of products that enable innovative solutions with sustainability benefits for hygiene and personal care applications at INDEX™23. This portfolio includes ExxonMobil™ PP, Achieve™ Advanced PP (polypropylene) and Vistamaxx™ performance polymers that can be used to create differentiated hygiene and personal care products.

An innovation being presented will be the model baby diaper of which the chassis is made exclusively with ExxonMobil’s extensive portfolio of products. Also on display will be a new version of the high-loft, ultra-soft, silky-smooth nonwoven solution for premium hygiene products using a blend of Vistamaxx™ performance polymers, Achieve™ Advanced PP and ExxonMobil™ PP. Developed collaboratively with Reifenhäuser Reicofil, this nonwoven solution delivers sustainability benefits by including ExxonMobil™ PP ISCC PLUS mass balance certified circular polymers using Exxtend™ technology for advanced recycling of plastic waste. Produced efficiently in one step from pellet to nonwoven via high-speed spunbond process, this soft nonwoven is ideal for use in premium diapers, pant-type diapers, feminine care and adult incontinence products.

The diabetic community has always been a priority for Hologenix, creators of CELLIANT® infrared technology, so the company embarked on an initial study to test the hypothesis that the technology can positively impact diabetic patients with vascular impairment, now published in Journal of Textile Science & Engineering. Another study is underway as well with more research on the horizon.

According to statistics cited in the International Diabetes Federation Diabetes Atlas, 9th edition, globally, close to a half billion people are living with diabetes and that number is expected to increase by more than 50 percent in the next 25 years.
 
The introduction of the study in the Journal of Textile Science & Engineering also reports that diabetic patients frequently suffer from a combination of peripheral neuropathy and peripheral artery disease, which particularly affects their feet. It further states that it has been estimated that the lifetime risk for the development of foot ulcers in diabetic patients can be as high as 25 percent and that the risk of amputation is 10 to 20 times higher than in non-diabetic subjects.
 
The study was performed by Lawrence A. Lavery, D.P.M., M.P.H., a Professor in the Department of Plastic Surgery at UT Southwestern Medical Center. His clinic and research interests involve diabetic foot complications, infections and wound healing, and he participated in the conception, design, implementation and authorship of the Journal of Textile Science & Engineering study.  

CELLIANT technology is a patented process for adding micron-sized thermo-responsive mineral particles to fibers, in this case polyethylene terephthalate (PET) fibers. The resulting CELLIANT yarns were woven into stockings and gloves containing either 82% CELLIANT polyester, 13% nylon and 5% spandex or for the placebo, 82% polyester with no CELLIANT, 13% nylon and 5% spandex. CELLIANT products absorb body heat and re-emit the energy back to the body as infrared energy, which is non-invasive and increases temporary blood flow and cell oxygenation levels in the body.

The objective of the study was to “evaluate changes in transcutaneous oxygen (TcPO2) and peripheral blood flow (laser Doppler, LD) in the hands and feet of diabetic patients with vascular impairment when CELLIANT gloves and stockings are worn.” While there was not a statistically significant result across all subjects, the study did show that some patients wearing CELLIANT stockings for 60 minutes had an increase of as much as 20% in tissue oxygenation and 30% in localized blood flow. According to the study’s conclusion, “the trends that were observed in favor of CELLIANT stockings suggest that a larger well-designed clinical trial should be undertaken and may provide evidence of clinical efficacy in treatment of the diabetic foot.”
 
The study also notes that “There have been no documented or observed side effects of wearing CELLIANT stockings, and they are relatively inexpensive compared to conventional pharmaceutical interventions.”

Hologenix has embarked on a more comprehensive trial, “Study to Evaluate CELLIANT Diabetic Medical Socks to Increase Tissue Oxygenation and Incidence of Complete Wound Closure in Diabetic Foot Wounds” – NCT04709419, which focuses on the impact of CELLIANT technology to potentially improve tissue oxygenation and wound healing outcomes.
 
“We are excited to explore whether future studies of infrared, with its most common biological effects of increased localized blood flow and cellular oxygenation, could result in a breakthrough in diabetic patients with vascular impairment,” said Seth Casden, Hologenix Co-founder and CEO. “We see a huge potential opportunity with this research for helping to fulfill our core mission of improving people’s health and well-being by potentially reducing the impact of diabetes, and we are actively seeking partners to expand our research efforts.”

After the recent acquisition of Texo S.R.L. which has strengthened the company's presence in the luxury segment, C&S takes a further step forward in the creation of a widespread garment manufacturing hub in the heart of Italy. C&S takes ownership of the Seville brand together with the Bianchetti family, who remain co-owners covering mainly style research and development functions. The Italian style, which amounts to an aesthetic identity and a guarantee of artisan quality, a cultural orientation toward manufacturing excellence and product design, finally to an approach to the market characterized by availability, openness and interaction with the customer.

This acquisition strengthens C&S direct contact with retail, going alongside HAIKURE, PDF and other brands still being finalized, and will be able to generate a profitable exchange with the Style Services Luxe and Style Services Denim divisions, through which C&S stands out as an exceptional partner for all the brands that choose to rely on its experience in the world of jeans, luxury and formalwear.

High quality and Made in Italy trousers, but there is more, the brand Siviglia from the Marche region brings to C&S a wealth of tailoring skills and product construction. Born in Marotta (PU) in 2006 from the Bianchetti family, Siviglia is a reality that has experienced rapid commercial success since its entry into the market thanks to the intuition of the iconic trousers with fabric inserts at mid-thigh inspired by the Spanish horsemen, hence the name that recalls the Andalusian capital.

The success of Siviglia is built on coats, trousers and jeans characterized by fit and linear style, thanks to the continuous research on the product, on the fabrics and on the emerging trends, in a personal reinterpretation of the codes of elegance. The corporate style permeates not only the choice of materials and accessories, but is distinguished by the packaging components and the use of visual and communicative languages in line with the brand identity. By interpreting the contemporary and foreseeing the future needs of a constantly evolving market, Siviglia aims to provide its customers with the best in the broadest sense, including among its qualitative goals the reduction of the environmental impact of productions and materials used.

B.I.G. has signed an agreement with Australian B2B flooring wholesaler to acquire its complete range of activities. Through this acquisition, both companies will strengthen their growth opportunities in both soft, resilient and hard flooring in Australia and New Zealand.

CEO Pol Deturck comments: “This acquisition will provide great opportunities for all our stakeholders, especially our customers, suppliers and employees. Both B.I.G. and Signature have solid positions as leaders in the flooring industry and a shared commitment to sustainability, product innovation, design and customer service.”

Signature Floors is an Australian B2B flooring wholesaler serving retailers, commercial contractors, architect-designers and end-users in Australia and New Zealand. Founded in 1989, the company has 120 employees and is owned by 2 family shareholders which are both active in the company. Signature has offices, warehouses and showrooms in Melbourne and Auckland spread over 3 locations.

Together, B.I.G. and Signature will integrate their sales and business activities over the coming months, ensuring business continuity for customers, partners, suppliers and employees.

Both companies expect to close the transaction at the end of April 2023.

Mimaki Europe kehrt in diesem Jahr als Goldsponsor auf die FESPA Global Print Expo 2023 zurück (23. bis 26. Mai in München, Deutschland). Mit seinen neuesten Innovationen, Technologien und Kooperationsprojekten wird das Unternehmen gemeinsam mit anderen Branchenvertretern auf der FESPA „neue Perspektiven“ präsentieren. Mimaki wird seine Flaggschiff-Drucker und -Schneideplotter für den Werbetechnik-, Industrie- und Textilmarkt vorstellen, darunter den kürzlich angekündigten DTF-Drucker (Direct-to-Film) TxF150-75, die leistungsstarke 330-Serie und die 100-Einstiegsserie.

TxF150-75, der auf der FESPA sein internationales Messedebüt geben wird, ist Mimakis erster Vorstoß in die DTF-Technologie, ein einfaches und kostengünstiges Verfahren zur Veredelung von Kleidungsstücken, vor allem T-Shirts. Durch die in das Gerät integrierten Kerntechnologien von Mimaki werden häufig auftretende DTF-Druckprobleme verhindert, z. B. schlechter Tintenausstoß und das Verstopfen der Düsen für weiße Tinte, sodass alle Prozesse effizient und mit minimalem Aufwand durchgeführt werden können.

Zu den weiteren bemerkenswerten Technologien, die auf der Messe gezeigt werden, gehören Mimakis Flaggschiffe für Sign Graphics, von der 100 Einstiegsserie bis zur 330-Hochleistungsserie. Der Druck- und Schneide-Workflow wird mit Mimakis neuestem Schneideplotter, dem CG-AR Serie, demonstriert. Aus dem industriellen Bereich von Mimaki können die Besucher die fortschrittlichen UV-Flachbettdrucker des Unternehmens erleben, vom kleineren UJF-6042 MkII e bis zum großformatigen JFX600-2513. Bei den Textildruckern werden die Sublimationsdrucker TS100-1600 und TS330-1600 zu sehen sein.

Ganz im Sinne des FESPA-Mottos „New Perspectives“ wird Mimaki die globale Messe nutzen, um die Druckindustrie mit einem verschärften Blick auf die Nachhaltigkeit in einem neuen Kontext zu betrachten. Das Unternehmen plant, sein Engagement in diesem Bereich zu bekräftigen und mit kreativen, umweltbewussten Experten aus der gesamten Branche zusammenzuarbeiten. In diesem Jahr wird Mimaki die von der Natur inspirierten Kunstwerke des niederländischen Surrealisten Rik Lina ausstellen.

Auch die bekannte Customer Gallery wird wieder zu sehen sein, dieses Mal mit einer Reihe von inspirierenden Anwendungen, die von Mimakis Kunden aus unterschiedlichen Bereichen erstellt wurden − vom Industrie- und Textildruck über die Werbetechnik bis hin zum 3D-Druck.

Paper Converting Machine Company (PCMC)—which specializes in the design and manufacture of high-performance converting machinery for the tissue, nonwovens, package-printing and bag-converting industries worldwide—announced that Windell McGill has joined the organization as the Product Launch Manager for its print business segment.

Bringing more than 25 years of print industry experience to PCMC, McGill will oversee product management, product launch and brand expansion for all PCMC print products and services.

Prior to joining PCMC, McGill was Managing Partner of ePac Atlanta, a provider of custom, high-quality flexible packaging solutions and digital printing services. Before that, he served as Business Segment Manager for flexible packaging at HP Indigo. McGill’s extensive experience also includes more than 15 years with Advanced Vision Technology, a provider of camera-based inspection equipment for the packaging market, where he held a variety of sales roles before being named President-Americas.

McGill will operate from his office in Atlanta.

• Beaulieu International Group and Arenal announce partnership

Padel pioneers Arenal and Artificial Grass specialists B.I.G. are pleased to announce the two companies have signed a long-term partnership to drive the growth of padel in the Belgian and Dutch markets. Over the last two years, padel has been growing exponentially, and as two market leaders, B.I.G. and Arenal are looking to further develop the sport. Arenal is a leading operator of padel courts in Belgium, looking to expand under the leadership of Marc Coucke, while B.I.G. is a leading provider for artificial grass surfaces for padel, ready to market its products under its Act Sports brand.

Today 18 million people play padel worldwide, and in Spain, Portugal and Sweden, there are now more active padel players than tennis players. The same growth is manifesting itself in Belgium and the Netherlands, where the number padel courts installed in the last 2 years has almost doubled.

For the recently opened 8-court Kerkrade facility, Arenal installed Act Sports' new Score Blue padel grass court. With a brand new textured yarn developed exclusively for padel, this product offers the perfect balance in terms of ball bounce, player comfort and game consistency. It can be used both for indoor and outdoor courts, and provides a high-quality, long-life system with low maintenance requirements.

Carbios announces the publication of an article entitled “Enzymes’ power for plastics degradation” in Chemical Reviews. The article is a comprehensive and critical review of research published to date on the enzymatic degradation of all types of plastics (PET, PLA, polyolefins, polyurethanes, polyamides) and includes almost 700 references. Co-authored by biotechnology researchers from Carbios and its academic partner Toulouse Biotechnology Institute (TBI), as well as two eminent professors in polymer science from the University of Bordeaux, the work brings together expertise in the fields of enzymology, polymer science and industry in order to accelerate the transition to a circular economy for plastic.

Beyond the comprehensive bibliographical study, the authors analyzed the data to discuss the scope, limitations, challenges and opportunities of enzymatic plastic recycling with a view to developing innovations and industrial processes. The article’s standpoint and added value with regard to issues surrounding plastic pollution is its critical view on technology transfer and industrial scalability.

To read the article in Chemical Reviews, click here.

Major developments FY 2022

• Currency-neutral revenues up 1% reflecting growth in all markets except Greater China
• Double-digit increases in North America and Latin America, EMEA up high single digits
• Gross margin declines to 47.3% due to strong increase in supply chain costs and discounting  
• Operating profit at € 669 million, including one-off costs of € 312 million
• Operating margin decreases to 3.0%  
• Net income (continuing operations) of € 254 million includes € 350 million one-off costs
• Executive and Supervisory Boards propose dividend of € 0.70 per share

Major developments Q4 2022

• Currency-neutral revenues decline 1% impacted by termination of Yeezy partnership
• Gross margin at 39.1% reflecting increased supply chain costs and higher discounting
• Operating loss of € 724 million
• Net loss from continuing operations of € 482 million

Outlook for 2023
Underlying operating profit expected to be around break-even level
In 2023, adidas expects currency-neutral revenues to decline at a high-single-digit rate as macroeconomic challenges and geopolitical tensions persist. Elevated recession risks in Europe and North America as well as uncertainty around the recovery in Greater China continue to exist. The company’s revenue development will also be impacted by the initiatives to significantly reduce high inventory levels. In addition, while the company continues to review future options for the utilization of its Yeezy inventory, the guidance already reflects the revenue loss of around € 1.2 billion from potentially not selling the existing stock. Accounting for the corresponding negative operating profit impact of around € 500 million, the company’s underlying operating profit is projected to be around the break-even level in 2023.

Reported operating loss of € 700 million projected
Should the company irrevocably decide not to repurpose any of the existing Yeezy product going forward, this would result in the potential write-off of the existing Yeezy inventory and would lower the company’s operating profit by an additional € 500 million this year. In addition, adidas expects one-off costs of up to € 200 million in 2023. These costs are part of a strategic review the company is currently conducting aimed at reigniting profitable growth as of 2024. If all these effects were to materialize, the company expects to report an operating loss of € 700 million in 2023.

A little over three years have passed since RadiciGroup announced the acquisition of Zeta Polimeri, an Italian company headquartered in Buronzo (VC) with over 30 years' experience in the recovery of pre- and post-consumer synthetic fibres and thermoplastic materials. Today, the company has become a full member of the Group with its new name Radici EcoMaterials Srl.

The new company’s long-standing know-how, combined with RadiciGroup’s as a whole, will create a virtuous production system that recovers worn-out materials (fabric, yarn and granules), or otherwise unusable materials, and processes them into raw materials available for other production cycles by taking advantage of industrial synergy.

Radici EcoMaterials is a strategic production site because it handles all the preliminary recovery stages: the sorting, processing and pre-treatment of materials, including those used for the production of post-consumer yarns and engineering polymers. In this sense, Radici EcoMaterials is in line with the most recent European policies on sustainable textiles, which address minimizing the share of materials destined for disposal sites, favouring instead more structured recycling solutions.

Radici EcoMaterials is also GRS certified. GRS certification ensures the complete traceability of its materials, which are made in a safe plant that meets the highest environmental and social certification standards.

The company is also equipped with a photovoltaic system and, for the portion of its energy needs not covered by the photovoltaic source, it partially relies on renewable energy. The goal is to use 100% green energy in the next few years, in accord with RadiciGroup's goals.